Wound repair and regeneration: Mechanisms, signaling, and translation

Science Translational Medicine

Volumn 6, Issue 265, 2014, Pages

  Eming, Sabine A ^a   Martin, Paul ^b,c   Tomic Canic, Marjana ^d  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; PROTEINASE; RECOMBINANT PLATELET DERIVED GROWTH FACTOR BB; VASCULOTROPIN; BIOLOGICAL MARKER; PEPTIDE HYDROLASE;

AGING; ANGIOGENESIS; CELL AGING; CELL THERAPY; CHRONIC DISEASE; DERMATITIS; DROSOPHILA; EPITHELIZATION; EXTRACELLULAR MATRIX; GENETIC ASSOCIATION; GRANULATION TISSUE; HEALTH CARE NEED; HUMAN; MANAGED CARE; MICROBIOME; MOLECULAR PATHOLOGY; NONHUMAN; PERSONALIZED MEDICINE; REVIEW; SIGNAL TRANSDUCTION; SKIN FIBROSIS; SKIN INJURY; SKIN SCAR; STEM CELL; STUDY DESIGN; TISSUE REGENERATION; TISSUE REPAIR; TRANSLATIONAL RESEARCH; WOUND DRESSING; WOUND HEALING; WOUND HEALING IMPAIRMENT; WOUND INFECTION; ZEBRA FISH; ANIMAL; CYTOLOGY; FIBROSIS; INFECTION; INFLAMMATION; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; REGENERATION; SCAR; SKIN;

AGING; ANIMALS; BIOMARKERS; CICATRIX; FIBROSIS; HUMANS; INFECTION; INFLAMMATION; MICE; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE HYDROLASES; REGENERATION; SIGNAL TRANSDUCTION; SKIN; STEM CELLS; TRANSLATIONAL MEDICAL RESEARCH; WOUND HEALING;

EID: 84915789422     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3009337     Document Type: Review

References (182)

1. C. K. Sen, G. M. Gordillo, S. Roy, R. Kirsner, L. Lambert, T. K. Hunt, F. Gottrup, G. C. Gurtner, M. T. Longaker, Human skin wounds: A major and snowballing threat to public health and the economy. Wound Repair Regen. 17, 763-771 (2009).
2. R. G. Reish, E. Eriksson, Scars: A review of emerging and currently available therapies. Plast. Reconstr. Surg. 122, 1068-1078 (2008).
3. H. Brem, M. Tomic-Canic, Cellular and molecular basis of wound healing in diabetes. J. Clin. Invest. 117, 1219-1222 (2007).
4. N. A. Richmond, S. A. Lamel, J. M. Davidson, M. Martins-Green, C. K. Sen, M. Tomic-Canic, A. C. Vivas, L. R. Braun, R. S. Kirsner, US - National Institutes of Health-funded research for cutaneous wounds in 2012. Wound Repair Regen. 21, 789-792 (2013).
5. J. J. Bergan, G. W. Schmid-Schönbein, P. D. Smith, A. N. Nicolaides, M. R. Boisseau, B. Eklof, Chronic venous disease. N. Engl. J. Med. 355, 488-498 (2006).
6. S. A. Eming, T. Krieg, J. M. Davidson, Inflammation in wound repair: Molecular and cellular mechanisms. J. Invest. Dermatol. 127, 514-525 (2007).
7. O. Stojadinovic, I. Pastar, S. Vukelic, M. G. Mahoney, D. Brennan, A. Krzyzanowska, M. Golinko, H. Brem, M. Tomic-Canic, Deregulation of keratinocyte differentiation and activation: A hallmark of venous ulcers. J. Cell. Mol. Med. 12, 2675-2690 (2008).
8. C. A. Charles, M. Tomic-Canic, V. Vincek, M. Nassiri, O. Stojadinovic, W. H. Eaglstein, R. S. Kirsner, A gene signature of nonhealing venous ulcers: Potential diagnostic markers. J. Am. Acad. Dermatol. 59, 758-771 (2008).
9. I. Pastar, A. A. Khan, O. Stojadinovic, E. A. Lebrun, M. C. Medina, H. Brem, R. S. Kirsner, J. J. Jimenez, C. Leslie, M. Tomic-Canic, Induction of specific microRNAs inhibits cutaneous wound healing. J. Biol. Chem. 287, 29324-29335 (2012).
10. C. J. Nolan, P. Damm, M. Prentki, Type 2 diabetes across generations: From pathophysiology to prevention and management. Lancet 378, 169-181 (2011).
11. D. G. Armstrong, J. Wrobel, J. M. Robbins, Guest editorial: Are diabetes-related wounds and amputations worse than cancer? Int. Wound J. 4, 286-287 (2007).
12. B. Aulivola, C. N. Hile, A. D. Hamdan, M. G. Sheahan, J. R. Veraldi, J. J. Skillman, D. R. Campbell, S. D. Scovell, F. W. LoGerfo, F. B. Pomposelli Jr., Major lower extremity amputation: Outcome of a modern series. Arch. Surg. 139, 395-399 (2004).
13. M. R. Sargen, O. Hoffstad, D. J. Margolis, Geographic variation in Medicare spending and mortality for diabetic patients with foot ulcers and amputations. J. Diabetes Complications 27, 128-133 (2013).
14. H. P. Lorenz, M. T. Longaker, L. A. Perkocha, R. W. Jennings, M. R. Harrison, N. S. Adzick, Scarless wound repair: A human fetal skin model. Development 114, 253-259 (1992).
15. P. Vidal, M. G. Dickson, Regeneration of the distal phalanx. A case report. J. Hand Surg. Br. 18, 230-233 (1993).
16. J. Canady, S. Karrer, M. Fleck, A. K. Bosserhoff, Fibrosing connective tissue disorders of the skin: Molecular similarities and distinctions. J. Dermatol. Sci. 70, 151-158 (2013).
17. B. Shih, A. Bayat, Genetics of keloid scarring. Arch. Dermatol. Res. 302, 319-339 (2010).
18. T. A. Wynn, T. R. Ramalingam, Mechanisms of fibrosis: Therapeutic translation for fibrotic disease. Nat. Med. 18, 1028-1040 (2012).
19. S. L. Friedman, D. Sheppard, J. S. Duffield, S. Violette, Therapy for fibrotic diseases: Nearing the starting line. Sci. Transl. Med. 5, 167sr161 (2013).
20. R. Nunan, K. G. Harding, P. Martin, Clinical challenges of chronic wounds: Searching for an optimal animalmodel to recapitulate their complexity. Dis. Model. Mech. 7, 1205-1213 (2014).
21. F. Larcher, J. Espada, B. Díaz-Ley, P. Jaén, A. Juarranz, M. Quintanilla, New experimental models of skin homeostasis and diseases. Actas Dermosifiliogr. 10.1016/j.ad.2014.03.008 (2014).
22. M. J. Martinez-Zapata, A. J. Martí-Carvajal, I. Solà, J. A. Expósito, I. Bolíbar, L. Rodríguez, J. Garcia, Autologous platelet-rich plasma for treating chronic wounds. Cochrane Database Syst. Rev. 10, CD006899 (2012).
23. C. Deppermann, D. Cherpokova, P. Nurden, J. N. Schulz, I. Thielmann, P. Kraft, T. Vögtle, C. Kleinschnitz, S. Dütting, G. Krohne, S. A. Eming, A. T. Nurden, B. Eckes, G. Stoll, D. Stegner, B. Nieswandt, Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice. J. Clin. Invest. 124, 237-250 (2014).
24. S. A. Eming, M. Hammerschmidt, T. Krieg, A. Roers, Interrelation of immunity and tissue repair or regeneration. Semin. Cell Dev. Biol. 20, 517-527 (2009).
25. S. A. Eming, M. Koch, A. Krieger, B. Brachvogel, S. Kreft, L. Bruckner-Tuderman, T. Krieg, J. D. Shannon, J. W. Fox, Differential proteomic analysis distinguishes tissue repair biomarker signatures in wound exudates obtained from normal healing and chronic wounds. J. Proteome Res. 9, 4758-4766 (2010).
26. S. K. Beidler, C. D. Douillet, D. F. Berndt, B. A. Keagy, P. B. Rich, W. A. Marston, Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy. J. Vasc. Surg. 49, 1013-1020 (2009).
27. A. Sindrilaru, T. Peters, S. Wieschalka, C. Baican, A. Baican, H. Peter, A. Hainzl, S. Schatz, Y. Qi, A. Schlecht, J. M. Weiss, M. Wlaschek, C. Sunderkötter, K. Scharffetter-Kochanek, An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J. Clin. Invest. 121, 985-997 (2011).
28. M. A. Loots, E. N. Lamme, J. Zeegelaar, J. R. Mekkes, J. D. Bos, E. Middelkoop, Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J. Invest. Dermatol. 111, 850-857 (1998).
29. S. Barrientos, O. Stojadinovic, M. S. Golinko, H. Brem, M. Tomic-Canic, Growth factors and cytokines in wound healing. Wound Repair Regen. 16, 585-601 (2008).
30. R. W. Tarnuzzer, G. S. Schultz, Biochemical analysis of acute and chronic wound environments. Wound Repair Regen. 4, 321-325 (1996).
31. L. Feldmeyer, M. Keller, G. Niklaus, D. Hohl, S. Werner, H. D. Beer, The inflammasome mediates UVB-induced activation and secretion of interleukin-1β by keratinocytes. Curr. Biol. 17, 1140-1145 (2007).
32. O. Stojadinovic, J. Minkiewicz, A. Sawaya, J. W. Bourne, P. Torzilli, J. P. de Rivero Vaccari, W. D. Dietrich, R. W. Keane, M. Tomic-Canic, Deep tissue injury in development of pressure ulcers: A decrease of inflammasome activation and changes in human skin morphology in response to aging and mechanical load. PLOS One 8, e69223 (2013).
33. I. Pastar, A. G. Nusbaum, J. Gil, S. B. Patel, J. Chen, J. Valdes, O. Stojadinovic, L. R. Plano, M. Tomic-Canic, S. C. Davis, Interactions of methicillin resistant Staphylococcus aureus USA300 and Pseudomonas aeruginosa in polymicrobial wound infection. PLOS One 8, e56846 (2013).
34. D. N. Frank, A. Wysocki, D. D. Specht-Glick, A. Rooney, R. A. Feldman, A. L. St Amand, N. R. Pace, J. D. Trent, Microbial diversity in chronic open wounds. Wound Repair Regen. 17, 163-172 (2009).
35. E. D. Roche, P. J. Renick, S. P. Tetens, S. J. Ramsay, E. Q. Daniels, D. L. Carson, Increasing the presence of biofilm and healing delay in a porcine model of MRSA-infected wounds. Wound Repair Regen. 20, 537-543 (2012).
36. J. M. Schröder, The role of keratinocytes in defense against infection. Curr. Opin. Infect. Dis. 23, 106-110 (2010).
37. V. Nizet, T. Ohtake, X. Lauth, J. Trowbridge, J. Rudisill, R. A. Dorschner, V. Pestonjamasp, J. Piraino, K. Huttner, R. L. Gallo, Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414, 454-457 (2001).
38. D. R. Yager, L. Y. Zhang, H. X. Liang, R. F. Diegelmann, I. K. Cohen, Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J. Invest. Dermatol. 107, 743-748 (1996).
39. M. Wlaschek, D. Peus, V. Achterberg, W. Meyer-Ingold, K. Scharffetter-Kochanek, Protease inhibitors protect growth factor activity in chronic wounds. Br. J. Dermatol. 137, 646 (1997).
40. N. Buchstein, D. Hoffmann, H. Smola, S. Lang, M. Paulsson, C. Niemann, T. Krieg, S. A. Eming, Alternative proteolytic processing of hepatocyte growth factor during wound repair. Am. J. Pathol. 174, 2116-2128 (2009).
41. G. Lauer, S. Sollberg, M. Cole, I. Flamme, J. Sturzebecher, K. Mann, T. Krieg, S. A. Eming, Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J. Invest. Dermatol. 115, 12-18 (2000).
42. C. Blanpain, E. Fuchs, Epidermal homeostasis: A balancing act of stem cells in the skin. Nat. Rev. Mol. Cell Biol. 10, 207-217 (2009).
43. B. A. Schmidt, V. Horsley, Intradermal adipocytes mediate fibroblast recruitment during skin wound healing. Development 140, 1517-1527 (2013).
44. W. C. Chou, M. Takeo, P. Rabbani, H. Hu, W. Lee, Y. R. Chung, J. Carucci, P. Overbeek, M. Ito, Direct migration of follicular melanocyte stem cells to the epidermis after wounding or UVB irradiation is dependent on Mc1r signaling. Nat. Med. 19, 924-929 (2013).
45. I. Pastar, O. Stojadinovic, A. Krzyzanowska, S. Barrientos, C. Stuelten, K. Zimmerman, M. Blumenberg, H. Brem, M. Tomic-Canic, Attenuation of the transforming growth factor β-signaling pathway in chronic venous ulcers. Mol. Med. 16, 92-101 (2010).
46. O. Stojadinovic, I. Pastar, A. G. Nusbaum, S. Vukelic, A. Krzyzanowska, M. Tomic-Canic, Deregulation of epidermal stem cell niche contributes to pathogenesis of nonhealing venous ulcers. Wound Repair Regen. 22, 220-227 (2014).
47. S. A. Eming, B. Brachvogel, T. Odorisio, M. Koch, Regulation of angiogenesis: Wound healing as a model. Prog. Histochem. Cytochem. 42, 115-170 (2007).
48. C. Krisp, F. Jacobsen, M. J. McKay, M. P. Molloy, L. Steinstraesser, D. A. Wolters, Proteome analysis reveals antiangiogenic environments in chronic wounds of diabetes mellitus type 2 patients. Proteomics 13, 2670-2681 (2013).
49. A. J. Leu, H. J. Leu, U. K. Franzeck, A. Bollinger, Microvascular changes in chronic venous insufficiency - A review. Cardiovasc. Surg. 3, 237-245 (1995).
50. D. C. Hoffmann, S. Willenborg, M. Koch, D. Zwolanek, S. Müller, A. K. Becker, S. Metzger, M. Ehrbar, P. Kurschat, M. Hellmich, J. A. Hubbell, S. A. Eming, Proteolytic processing regulates placental growth factor activities. J. Biol. Chem. 288, 17976-17989 (2013).
51. L. E. Edsberg, J. T. Wyffels, M. S. Brogan, K. M. Fries, Analysis of the proteomic profile of chronic pressure ulcers. Wound Repair Regen. 20, 378-401 (2012).
52. P. Romagnani, L. Lasagni, F. Annunziato, M. Serio, S. Romagnani, CXC chemokines: The regulatory link between inflammation and angiogenesis. Trends Immunol. 25, 201-209 (2004).
53. F. Rodier, J. Campisi, Four faces of cellular senescence. J. Cell Biol. 192, 547-556 (2011).
54. I. B. Wall, R. Moseley, D. M. Baird, D. Kipling, P. Giles, I. Laffafian, P. E. Price, D. W. Thomas, P. Stephens, Fibroblast dysfunction is a key factor in the non-healing of chronic venous leg ulcers. J. Invest. Dermatol. 128, 2526-2540 (2008).
55. H. Brem, M. S. Golinko, O. Stojadinovic, A. Kodra, R. F. Diegelmann, S. Vukelic, H. Entero, D. L. Coppock, M. Tomic-Canic, Primary cultured fibroblasts derived from patients with chronic wounds: A methodology to produce human cell lines and test putative growth factor therapy such as GMCSF. J. Transl. Med. 6, 75 (2008).
56. T. M. Blazić, I. Brajac, Defective induction of senescence during wound healing is a possible mechanism of keloid formation. Med. Hypotheses 66, 649-652 (2006).
57. J. I. Jun, L. F. Lau, The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat. Cell Biol. 12, 676-685 (2010).
58. B. J. Nickoloff, M. W. Lingen, B. D. Chang, M. Shen, M. Swift, J. Curry, P. Bacon, B. Bodner, I. B. Roninson, Tumor suppressor maspin is up-regulated during keratinocyte senescence, exerting a paracrine antiangiogenic activity. Cancer Res. 64, 2956-2961 (2004).
59. J. P. Coppé, C. K. Patil, F. Rodier, Y. Sun, D. P. Munoz, J. Goldstein, P. S. Nelson, P. Y. Desprez, J. Campisi, Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLOS Biol. 6, 2853-2868 (2008).
60. S. Barrientos, H. Brem, O. Stojadinovic, M. Tomic-Canic, Clinical application of growth factors and cytokines in wound healing. Wound Repair Regen. 22, 569-578 (2014).
61. R. M. Da Costa, F. M. Ribeiro Jesus, C. Aniceto, M. Mendes, Randomized, double-blind, placebo-controlled, dose-ranging study of granulocyte-macrophage colony stimulating factor in patients with chronic venous leg ulcers. Wound Repair Regen. 7, 17-25 (1999).
62. J. M. Smiell, T. J. Wieman, D. L. Steed, B. H. Perry, A. R. Sampson, B. H. Schwab, Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: A combined analysis of four randomized studies. Wound Repair Regen. 7, 335-346 (1999).
63. N. Ziyadeh, D. Fife, A. M. Walker, G. S. Wilkinson, J. D. Seeger, A matched cohort study of the risk of cancer in users of becaplermin. Adv. Skin Wound Care 24, 31-39 (2011).
64. N. Morimoto, K. Yoshimura, M. Niimi, T. Ito, H. Tada, S. Teramukai, T. Murayama, C. Toyooka, S. Takemoto, K. Kawai, M. Yokode, A. Shimizu, S. Suzuki, An exploratory clinical trial for combination wound therapy with a novel medical matrix and fibroblast growth factor in patients with chronic skin ulcers: A study protocol. Am. J. Transl. Res. 4, 52-59 (2012).
65. S. Werner, H. Smola, X. Liao, M. T. Longaker, T. Krieg, P. H. Hofschneider, L. T. Williams, The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science 266, 819-822 (1994).
66. K. F. Bradstock, E. Link, M. Collins, J. Di Iulio, I. D. Lewis, A. Schwarer, A. Enno, P. Marlton, U. Hahn, J. Szer, G. Cull, J. F. Seymour; the Australian Leukaemia and Lymphoma Group, A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia. Br. J. Haematol. 167, 618-625 (2014).
67. N. Ferrara, Vascular endothelial growth factor: Basic science and clinical progress. Endocr. Rev. 25, 581-611 (2004).
68. S. Ylä-Herttuala, K. Alitalo, Gene transfer as a tool to induce therapeutic vascular growth. Nat. Med. 9, 694-701 (2003).
69. J. R. Hanft, R. A. Pollak, A. Barbul, C. van Gils, P. S. Kwon, S. M. Gray, C. J. Lynch, C. P. Semba, T. J. Breen, Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers. J. Wound Care 17, 30-32, 34-37 (2008).
70. J. G. Rheinwald, H. Green, Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells. Cell 6, 331-343 (1975).
71. F. Berthiaume, T. J. Maguire, M. L. Yarmush, Tissue engineering and regenerative medicine: History, progress, and challenges. Annu. Rev. Chem. Biomol. Eng. 2, 403-430 (2011).
72. R. C. Rennert, M. Rodrigues, V. W. Wong, D. Duscher, M. Hu, Z. Maan, M. Sorkin, G. C. Gurtner, M. T. Longaker, Biological therapies for the treatment of cutaneous wounds: Phase III and launched therapies. Expert Opin. Biol. Ther. 13, 1523-1541 (2013).
73. H. Brem, O. Stojadinovic, R. F. Diegelmann, H. Entero, B. Lee, I. Pastar, M. Golinko, H. Rosenberg, M. Tomic-Canic, Molecular markers in patients with chronic wounds to guide surgical debridement. Mol. Med. 13, 30-39 (2007).
74. G. S. Schultz, M. White, R. Mitchell, G. Brown, J. Lynch, D. R. Twardzik, G. J. Todaro, Epithelial wound healing enhanced by transforming growth factor-alpha and vaccinia growth factor. Science 235, 350-352 (1987).
75. T. P. Sullivan, W. H. Eaglstein, S. C. Davis, P. Mertz, The pig as a model for human wound healing. Wound Repair Regen. 9, 66-76 (2001).
76. R. Grose, S. Werner, Wound-healing studies in transgenic and knockout mice. Mol. Biotechnol. 28, 147-166 (2004).
77. L. Cooper, C. Johnson, F. Burslem, P. Martin, Wound healing and inflammation genes revealed by array analysis of 'macrophageless' PU.1 null mice. Genome Biol. 6, R5 (2005).
78. T. X. Pedersen, C. Leethanakul, V. Patel, D. Mitola, L. R. Lund, K. Danø, M. Johnsen, J. S. Gutkind, T. H. Bugge, Laser capture microdissection-based in vivo genomic profiling of wound keratinocytes identifies similarities and differences to squamous cell carcinoma. Oncogene 22, 3964-3976 (2003).
79. R. D. Paladini, K. Takahashi, N. S. Bravo, P. A. Coulombe, Onset of re-epithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: Defining a potential role for keratin 16. J. Cell Biol. 132, 381-397 (1996).
80. P. Martin, C. D. Nobes, An early molecular component of the wound healing response in rat embryos - Induction of c-fos protein in cells at the epidermal wound margin. Mech. Dev. 38, 209-215 (1992).
81. R. Grose, B. S. Harris, L. Cooper, P. Topilko, P. Martin, Immediate early genes krox-24 and krox-20 are rapidly up-regulated after wounding in the embryonic and adult mouse. Dev. Dyn. 223, 371-378 (2002).
82. T. Shaw, P. Martin, Epigenetic reprogramming during wound healing: Loss of polycomb-mediated silencing may enable upregulation of repair genes. EMBO Rep. 10, 881-886 (2009).
83. R. Grose, C. Hutter, W. Bloch, I. Thorey, F. M. Watt, R. Fässler, C. Brakebusch, S. Werner, A crucial role of b1 integrins for keratinocyte migration in vitro and during cutaneous wound repair. Development 129, 2303-2315 (2002).
84. H. A. Thomason, N. H. Cooper, D. M. Ansell, M. Chiu, A. J. Merrit, M. J. Hardman, D. R. Garrod, Direct evidence that PKCα positively regulates wound re-epithelialization: Correlation with changes in desmosomal adhesiveness. J. Pathol. 227, 346-356 (2012).
85. S. E. Gill, W. C. Parks, Metalloproteinases and their inhibitors: Regulators of wound healing. Int. J. Biochem. Cell Biol. 40, 1334-1347 (2008).
86. J. Chmielowiec, M. Borowiak, M. Morkel, T. Stradal, B. Munz, S. Werner, J. Wehland, C. Birchmeier, W. Birchmeier, c-Met is essential for wound healing in the skin. J. Cell Biol. 177, 151-162 (2007).
87. M. Meyer, A. K. Müller, J. Yang, D. Moik, G. Ponzio, D. M. Ornitz, R. Grose, S. Werner, FGF receptors 1 and 2 are key regulators of keratinocyte migration in vitro and in wounded skin. J. Cell Sci. 125, 5690-5701 (2012).
88. S. K. Repertinger, E. Campagnaro, J. Fuhrman, T. El-Abaseri, S. H. Yuspa, L. A. Hansen, EGFR enhances early healing after cutaneous incisional wounding. J. Invest. Dermatol. 123, 982-989 (2004).
89. M. Ito, Y. Liu, Z. Yang, J. Nguyen, F. Liang, R. J. Morris, G. Cotsarelis, Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat. Med. 11, 1351-1354 (2005).
90. V. Levy, C. Lindon, Y. Zheng, B. D. Harfe, B. A. Morgan, Epidermal stem cells arise from the hair follicle after wounding. FASEB J. 21, 1358-1366 (2007).
91. M. Ito, Z. Yang, T. Andl, C. Cui, N. Kim, S. E. Millar, G. Cotsarelis, Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding. Nature 447, 316-320 (2007).
92. A. Desmoulière, A. Geinoz, F. Gabbiani, G. Gabbiani, Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 122, 103-111 (1993).
93. C. Fathke, L. Wilson, J. Hutter, V. Kapoor, A. Smith, A. Hocking, F. Isik, Contribution of bone marrow-derived cells to skin: Collagen deposition and wound repair. Stem Cells 22, 812-822 (2004).
94. G. Ishii, T. Sangai, K. Sugiyama, T. Ito, T. Hasebe, Y. Endoh, J. Magae, A. Ochiai, In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions. Stem Cells 23, 699-706 (2005).
95. M. Sasaki, R. Abe, Y. Fujita, S. Ando, D. Inokuma, H. Shimizu, Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J. Immunol. 180, 2581-2587 (2008).
96. V. Falanga, S. Iwamoto, M. Chartier, T. Yufit, J. Butmarc, N. Kouttab, D. Shrayer, P. Carson, Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng. 13, 1299-1312 (2007).
97. E. V. Badiavas, V. Falanga, Treatment of chronic wounds with bone marrow-derived cells. Arch. Dermatol. 139, 510-516 (2003).
98. R. R. Driskell, B. M. Lichtenberger, E. Hoste, K. Kretzschmar, B. D. Simons, M. Charalambous, S. R. Ferron, Y. Herault, G. Pavlovic, A. C. Ferguson-Smith, F. M. Watt, Distinct fibroblast lineages determine dermal architecture in skin development and repair. Nature 504, 277-281 (2013).
99. J. Hopkinson-Woolley, D. Hughes, S. Gordon, P. Martin, Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse. J. Cell Sci. 107 (Pt. 5), 1159-1167 (1994).
100. N. S. Adzick, M. R. Harrison, P. L. Glick, J. H. Beckstead, R. L. Villa, H. Scheuenstuhl, W. H. Goodson III, Comparison of fetal, newborn, and adult wound healing by histologic, enzyme-histochemical, and hydroxyproline determinations. J. Pediatr. Surg. 20, 315-319 (1985).
101. P. Martin, D. D'Souza, J. Martin, R. Grose, L. Cooper, R. Maki, S. R. McKercher, Wound healing in the PU.1 null mouse - Tissue repair is not dependent on inflammatory cells. Curr. Biol. 13, 1122-1128 (2003).
102. J. V. Dovi, L. K. He, L. A. DiPietro, Accelerated wound closure in neutrophil-depleted mice. J. Leukoc. Biol. 73, 448-455 (2003).
103. T. Lucas, A. Waisman, R. Ranjan, J. Roes, T. Krieg, W. Müller, A. Roers, S. A. Eming, Differential roles of macrophages in diverse phases of skin repair. J. Immunol. 184, 3964-3977 (2010).
104. M. Antsiferova, C. Martin, M. Huber, T. B. Feyerabend, A. Förster, K. Hartmann, H. R. Rodewald, D. Hohl, S. Werner, Mast cells are dispensable for normal and activin-promoted wound healing and skin carcinogenesis. J. Immunol. 191, 6147-6155 (2013).
105. S. Willenborg, B. Eckes, J. Brinckmann, T. Krieg, A. Waisman, K. Hartmann, A. Roers, S. A. Eming, Genetic ablation of mast cells redefines the role of mast cells in skin wound healing and bleomycin-induced fibrosis. J. Invest. Dermatol. 134, 2005-2015 (2014).
106. J. Jameson, K. Ugarte, N. Chen, P. Yachi, E. Fuchs, R. Boismenu, W. L. Havran, A role for skin γδ T cells in wound repair. Science 296, 747-749 (2002).
107. M. E. Bianchi, A. A. Manfredi, Immunology. Dangers in and out. Science 323, 1683-1684 (2009).
108. V. W. Wong, K. C. Rustad, S. Akaishi, M. Sorkin, J. P. Glotzbach, M. Januszyk, E. R. Nelson, K. Levi, J. Paterno, I. N. Vial, A. A. Kuang, M. T. Longaker, G. C. Gurtner, Focal adhesion kinase links mechanical force to skin fibrosis via inflammatory signaling. Nat. Med. 18, 148-152 (2011).
109. M. W. Ferguson, S. O'Kane, Scar-free healing: From embryonic mechanisms to adult therapeutic intervention. Philos. Trans. R Soc. Lond. B Biol. Sci. 359, 839-850 (2004).
110. R. Mori, T. J. Shaw, P. Martin, Molecular mechanisms linking wound inflammation and fibrosis: Knockdown of osteopontin leads to rapid repair and reduced scarring. J. Exp. Med. 205, 43-51 (2008).
111. B. Munz, S. Frank, G. Hübner, E. Olsen, S. Werner, A novel type of glutathione peroxidase: Expression and regulation during wound repair. Biochem. J. 326 (Pt. 2), 579-585 (1997).
112. E. Emmerson, M. J. Hardman, The role of estrogen deficiency in skin ageing and wound healing. Biogerontology 13, 3-20 (2012).
113. L. M. Pyter, L. Yang, J. M. da Rocha, C. G. Engeland, The effects of social isolation on wound healing mechanisms in female mice. Physiol. Behav. 127, 64-70 (2014).
114. D. M. Ansell, J. E. Kloepper, H. A. Thomason, R. Paus, M. J. Hardman, Exploring the "hair growth-wound healing connection": Anagen phase promotes wound re-epithelialization. J. Invest. Dermatol. 131, 518-528 (2011).
115. D. G. Greenhalgh, K. H. Sprugel, M. J. Murray, R. Ross, PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am. J. Pathol. 136, 1235-1246 (1990).
116. R. K. Chan, P. H. Liu, G. Pietramaggiori, S. I. Ibrahim, H. B. Hechtman, D. P. Orgill, Effect of recombinant platelet-derived growth factor (Regranex®) on wound closure in genetically diabetic mice. J. Burn Care Res. 27, 202-205 (2006).
117. W. Razzell, W. Wood, P. Martin, Swatting flies: Modelling wound healing and inflammation in Drosophila. Dis. Model. Mech. 4, 569-574 (2011).
118. K. M. Henry, C. A. Loynes, M. K. Whyte, S. A. Renshaw, Zebrafish as a model for the study of neutrophil biology. J. Leukoc. Biol. 94, 633-642 (2013).
119. B. Stramer, W. Wood, M. J. Galko, M. J. Redd, A. Jacinto, S. M. Parkhurst, P. Martin, Live imaging of wound inflammation in Drosophila embryos reveals key roles for small GTPases during in vivo cell migration. J. Cell Biol. 168, 567-573 (2005).
120. W. Wood, A. Jacinto, R. Grose, S. Woolner, J. Gale, C. Wilson, P. Martin, Wound healing recapitulates morphogenesis in Drosophila embryos. Nat. Cell Biol. 4, 907-912 (2002).
121. W. Razzell, W. Wood, P. Martin, Recapitulation of morphogenetic cell shape changes enables wound re-epithelialisation. Development 141, 1814-1820 (2014).
122. C. Lesch, J. Jo, Y. Wu, G. S. Fish, M. J. Galko, A targeted UAS-RNAi screen in Drosophila larvae identifies wound closure genes regulating distinct cellular processes. Genetics 186, 943-957 (2010).
123. I. Campos, J. A. Geiger, A. C. Santos, V. Carlos, A. Jacinto, Genetic screen in Drosophila melanogaster uncovers a novel set of genes required for embryonic epithelial repair. Genetics 184, 129-140 (2010).
124. K. A. Mace, J. C. Pearson, W. McGinnis, An epidermal barrier wound repair pathway in Drosophila is mediated by grainy head. Science 308, 381-385 (2005).
125. S. B. Ting, J. Caddy, N. Hislop, T. Wilanowski, A. Auden, L. L. Zhao, S. Ellis, P. Kaur, Y. Uchida, W. M. Holleran, P. M. Elias, J. M. Cunningham, S. M. Jane, A homolog of Drosophila grainy head is essential for epidermal integrity in mice. Science 308, 411-413 (2005).
126. J. Caddy, T. Wilanowski, C. Darido, S. Dworkin, S. B. Ting, Q. Zhao, G. Rank, A. Auden, S. Srivastava, T. A. Papenfuss, J. N. Murdoch, P. O. Humbert, V. Parekh, N. Boulos, T. Weber, J. Zuo, J. M. Cunningham, S. M. Jane, Epidermal wound repair is regulated by the planar cell polarity signaling pathway. Dev. Cell 19, 138-147 (2010).
127. P. Niethammer, C. Grabher, A. T. Look, T. J. Mitchison, A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 459, 996-999 (2009).
128. L. Pase, J. E. Layton, C. Wittmann, F. Ellett, C. J. Nowell, C. C. Reyes-Aldasoro, S. Varma, K. L. Rogers, C. J. Hall, M. C. Keightley, P. S. Crosier, C. Grabher, J. K. Heath, S. A. Renshaw, G. J. Lieschke, Neutrophil-delivered myeloperoxidase dampens the hydrogen peroxide burst after tissue wounding in zebrafish. Curr. Biol. 22, 1818-1824 (2012).
129. R. Richardson, K. Slanchev, C. Kraus, P. Knyphausen, S. Eming, M. Hammerschmidt, Adult zebrafish as a model system for cutaneous wound-healing research. J. Invest. Dermatol. 133, 1655-1665 (2013).
130. P. Murawala, E. M. Tanaka, J. D. Currie, Regeneration: The ultimate example of wound healing. Semin. Cell Dev. Biol. 23, 954-962 (2012).
131. A. Kumar, J. P. Brockes, Nerve dependence in tissue, organ, and appendage regeneration. Trends Neurosci. 35, 691-699 (2012).
132. S. Harsum, J. D. Clarke, P. Martin, A reciprocal relationship between cutaneous nerves and repairing skin wounds in the developing chick embryo. Dev. Biol. 238, 27-39 (2001).
133. T. Fukazawa, Y. Naora, T. Kunieda, T. Kubo, Suppression of the immune response potentiates tadpole tail regeneration during the refractory period. Development 136, 2323-2327 (2009).
134. J. W. Godwin, A. R. Pinto, N. A. Rosenthal, Macrophages are required for adult salamander limb regeneration. Proc. Natl. Acad. Sci. U.S.A. 110, 9415-9420 (2013).
135. T. A. Petrie, N. S. Strand, C. Tsung-Yang, J. S. Rabinowitz, R. T. Moon, Macrophages modulate adult zebrafish tail fin regeneration. Development 141, 2581-2591 (2014).
136. R. O. Hynes, The extracellular matrix: Not just pretty fibrils. Science 326, 1216-1219 (2009).
137. J. F. Bateman, R. P. Boot-Handford, S. R. Lamandé, Genetic diseases of connective tissues: Cellular and extracellular effects of ECM mutations. Nat. Rev. Genet. 10, 173-183 (2009).
138. J. P. Habashi, D. P. Judge, T. M. Holm, R. D. Cohn, B. L. Loeys, T. K. Cooper, L. Myers, E. C. Klein, G. Liu, C. Calvi, M. Podowski, E. R. Neptune, M. K. Halushka, D. Bedja, K. Gabrielson, D. B. Rifkin, L. Carta, F. Ramirez, D. L. Huso, H. C. Dietz, Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312, 117-121 (2006).
139. S. F. Badylak, D. J. Weiss, A. Caplan, P. Macchiarini, Engineered whole organs and complex tissues. Lancet 379, 943-952 (2012).
140. R. S. Kirsner, W. A. Marston, R. J. Snyder, T. D. Lee, D. I. Cargill, H. B. Slade, Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: A phase 2, multicentre, double-blind, randomised, placebo-controlled trial. Lancet 380, 977-985 (2012).
141. M. Potente, H. Gerhardt, P. Carmeliet, Basic and therapeutic aspects of angiogenesis. Cell 146, 873-887 (2011).
142. M. M. Martino, F. Tortelli, M. Mochizuki, S. Traub, D. Ben-David, G. A. Kuhn, R. Müller, E. Livne, S. A. Eming, J. A. Hubbell, Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci. Transl. Med. 3, 100ra189 (2011).
143. 165. Biomaterials 34, 5958-5968 (2013).
144. M. P. Lutolf, J. A. Hubbell, Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 23, 47-55 (2005).
145. A. Zieris, S. Prokoph, K. R. Levental, P. B. Welzel, M. Grimmer, U. Freudenberg, C. Werner, FGF-2 and VEGF functionalization of starPEG - heparin hydrogels to modulate biomolecular and physical cues of angiogenesis. Biomaterials 31, 7985-7994 (2010).
146. K. A. Mosiewicz, L. Kolb, A. J. van der Vlies, M. M. Martino, P. S. Lienemann, J. A. Hubbell, M. Ehrbar, M. P. Lutolf, In situ cell manipulation through enzymatic hydrogel photopatterning. Nat. Mater. 12, 1072-1078 (2013).
147. P. M. Gilbert, K. L. Havenstrite, K. E. Magnusson, A. Sacco, N. A. Leonardi, P. Kraft, N. K. Nguyen, S. Thrun, M. P. Lutolf, H. M. Blau, Substrate elasticity regulates skeletal muscle stem cell selfrenewal in culture. Science 329, 1078-1081 (2010).
148. D. E. Discher, D. J. Mooney, P. W. Zandstra, Growth factors, matrices, and forces combine and control stem cells. Science 324, 1673-1677 (2009).
149. S. Dupont, L. Morsut, M. Aragona, E. Enzo, S. Giulitti, M. Cordenonsi, F. Zanconato, J. Le Digabel, M. Forcato, S. Bicciato, N. Elvassore, S. Piccolo, Role of YAP/TAZ in mechanotransduction. Nature 474, 179-183 (2011).
150. N. R. Dash, S. N. Dash, P. Routray, S. Mohapatra, P. C. Mohapatra, Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells. Rejuvenation Res. 12, 359-366 (2009).
151. J. E. Wagner, A. Ishida-Yamamoto, J. A. McGrath, M. Hordinsky, D. R. Keene, D. T. Woodley, M. Chen, M. J. Riddle, M. J. Osborn, T. Lund, M. Dolan, B. R. Blazar, J. Tolar, Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N. Engl. J. Med. 363, 629-639 (2010).
152. P. Donndorf, B. E. Strauer, G. Steinhoff, Update on cardiac stem cell therapy in heart failure. Curr. Opin. Cardiol. 27, 154-160 (2012).
153. M. Itoh, N. Umegaki-Arao, Z. Guo, L. Liu, C. A. Higgins, A. M. Christiano, Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs). PLOS One 8, e77673 (2013).
154. V. Sebastiano, H. H. Zhen, B. Haddad Derafshi, E. Bashkirova, S. P. Melo, P. Wang, T. L. Leung, Z. Siprashvili, A. Tichy, J. Li, M. Ameen, J. Hawkins, S. Lee, L. Li, A. Schwertschkow, G. Bauer, L. Lisowski, M. Kay, S. K. Kim, A. T. Lane, M. Wernig, A. E. Oro, Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa. Sci. Transl. Med. 6, 264ra163 (2014).
155. N. Umegaki-Arao, A. M. G. Pasmooij, M. Itoh, J. E. Cerise, Z. Guo, B. Levy, A. Gostyński, L. R. Rothman, M. F. Jonkman, A. M. Christiano, Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa. Sci. Transl. Med. 6, 264ra164 (2014).
156. T. Himeno, H. Kamiya, K. Naruse, Z. Cheng, S. Ito, M. Kondo, T. Okawa, A. Fujiya, J. Kato, H. Suzuki, T. Kito, Y. Hamada, Y. Oiso, K. Isobe, J. Nakamura, Mesenchymal stem cell-like cells derived from mouse induced pluripotent stem cells ameliorate diabetic polyneuropathy in mice. Biomed. Res. Int. 2013, 259187 (2013).
157. Y. Shamis, E. A. Silva, K. J. Hewitt, Y. Brudno, S. Levenberg, D. J. Mooney, J. A. Garlick, Fibroblasts derived from human pluripotent stem cells activate angiogenic responses in vitro and in vivo. PLOS One 8, e83755 (2013).
158. S. Doulatov, G. Q. Daley, Development. A stem cell perspective on cellular engineering. Science 342, 700-702 (2013).
159. D. Sipp, L. Turner, Stem cells. U.S. regulation of stem cells as medical products. Science 338, 1296-1297 (2012).
160. A. D. Maderal, A. C. Vivas, W. H. Eaglstein, R. S. Kirsner, The FDA and designing clinical trials for chronic cutaneous ulcers. Semin. Cell Dev. Biol. 23, 993-999 (2012).
161. A. D. Maderal, A. C. Vivas, T. G. Zwick, R. S. Kirsner, Diabetic foot ulcers: Evaluation and management. Hosp. Prac. 40, 102-115 (2012).
162. E. A. Grice, H. H. Kong, S. Conlan, C. B. Deming, J. Davis, A. C. Young; NISC Comparative Sequencing Program, G. G. Bouffard, R. W. Blakesley, P. R. Murray, E. D. Green, M. L. Turner, J. A. Segre, Topographical and temporal diversity of the human skin microbiome. Science 324, 1190-1192 (2009).
163. A. M. Misic, S. E. Gardner, E. A. Grice, The wound microbiome: Modern approaches to examining the role of microorganisms in impaired chronic wound healing. Adv. Wound Care 3, 502-510 (2014).
164. P. L. Zeeuwen, J. Boekhorst, E. H. van den Bogaard, H. D. de Koning, P. M. van de Kerkhof, D. M. Saulnier, I. I. van Swam, S. A. van Hijum, M. Kleerebezem, J. Schalkwijk, H. M. Timmerman, Microbiome dynamics of human epidermis following skin barrier disruption. Genome Biol. 13, R101 (2012).
165. S. E. Gardner, S. L. Hillis, K. Heilmann, J. A. Segre, E. A. Grice, The neuropathic diabetic foot ulcer microbiome is associated with clinical factors. Diabetes 62, 923-930 (2013).
166. G. A. James, E. Swogger, R. Wolcott, E. Pulcini, P. Secor, J. Sestrich, J. W. Costerton, P. S. Stewart, Biofilms in chronic wounds. Wound Repair Regen. 16, 37-44 (2008).
167. L. B. Price, C. M. Liu, J. H. Melendez, Y. M. Frankel, D. Engelthaler, M. Aziz, J. Bowers, R. Rattray, J. Ravel, C. Kingsley, P. S. Keim, G. S. Lazarus, J. M. Zenilman, Community analysis of chronic wound bacteria using 16S rRNA gene-based pyrosequencing: Impact of diabetes and antibiotics on chronic wound microbiota. PLOS One 4, e6462 (2009).
168. V. Gontcharova, E. Youn, Y. Sun, R. D. Wolcott, S. E. Dowd, A comparison of bacterial composition in diabetic ulcers and contralateral intact skin. Open Microbiol. J. 4, 8-19 (2010).
169. G. S. Ashcroft, M. A. Horan, M. W. Ferguson, Aging is associated with reduced deposition of specific extracellular matrix components, an upregulation of angiogenesis, and an altered inflammatory response in a murine incisional wound healing model. J. Invest. Dermatol. 108, 430-437 (1997).
170. S. D. Tyner, S. Venkatachalam, J. Choi, S. Jones, N. Ghebranious, H. Igelmann, X. Lu, G. Soron, B. Cooper, C. Brayton, S. H. Park, T. Thompson, G. Karsenty, A. Bradley, L. A. Donehower, p53 mutant mice that display early ageing-associated phenotypes. Nature 415, 45-53 (2002).
171. E. A. Grice, E. S. Snitkin, L. J. Yockey, D. M. Bermudez; NISC Comparative Sequencing Program, K. W. Liechty, J. A. Segre, Longitudinal shift in diabetic wound microbiota correlates with prolonged skin defense response. Proc. Natl. Acad. Sci. U.S.A. 107, 14799-14804 (2010).
172. M. J. Hardman, G. S. Ashcroft, Estrogen, not intrinsic aging, is the major regulator of delayed human wound healing in the elderly. Genome Biol. 9, R80 (2008).
173. S. C. Gilliver, J. J. Ashworth, S. J. Mills, M. J. Hardman, G. S. Ashcroft, Androgens modulate the inflammatory response during acute wound healing. J. Cell Sci. 119, 722-732 (2006).
174. J. J. Ashworth, J. V. Smyth, N. Pendleton, M. Horan, A. Payton, J. Worthington, W. E. Ollier, G. S. Ashcroft, Polymorphisms spanning the 0N exon and promoter of the estrogen receptor-beta (ERβ) gene ESR2 are associated with venous ulceration. Clin. Genet. 73, 55-61 (2008).
175. G. S. Ashcroft, J. Dodsworth, E. van Boxtel, R. W. Tarnuzzer, M. A. Horan, G. S. Schultz, M. W. Ferguson, Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels. Nat. Med. 3, 1209-1215 (1997).
176. G. S. Ashcroft, T. Greenwell-Wild, M. A. Horan, S. M. Wahl, M. W. Ferguson, Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am. J. Pathol. 155, 1137-1146 (1999).
177. C. López-Otín, M. A. Blasco, L. Partridge, M. Serrano, G. Kroemer, The hallmarks of aging. Cell 153, 1194-1217 (2013).
178. O. Stojadinovic, H. Brem, C. Vouthounis, B. Lee, J. Fallon, M. Stallcup, A. Merchant, R. D. Galiano, M. Tomic-Canic, Molecular pathogenesis of chronic wounds: The role of β-catenin and c-myc in the inhibition of epithelialization and wound healing. Am. J. Pathol. 167, 59-69 (2005).
179. D. D. Rhoads, S. B. Cox, E. J. Rees, Y. Sun, R. D. Wolcott, Clinical identification of bacteria in human chronic wound infections: Culturing vs. 16S ribosomal DNA sequencing. BMC Infect. Dis. 12, 321 (2012).
180. R. J. Snyder, V. Driver, C. E. Fife, J. Lantis, B. Peirce, T. Serena, D. Weir, Using a diagnostic tool to identify elevated protease activity levels in chronic and stalled wounds: A consensus panel discussion. Ostomy Wound Manage. 57, 36-46 (2011).
181. D. Taverna, L. B. Nanney, A. C. Pollins, G. Sindona, R. Caprioli, Multiplexed molecular descriptors of pressure ulcers defined by imaging mass spectrometry. Wound Repair Regen. 19, 734-744 (2011).
182. C. Suihko, J. Serup, Fluorescent fibre-optic confocal imaging of lesional and non-lesional psoriatic skin compared with normal skin in vivo. Skin Res. Technol. 18, 397-404 (2012).